Raymond James Financial Services Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Raymond James Financial Services Advisors’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-30,543	Closed	-$729K	–	2952
2019 Q4	$729K	Sell	30,543 -925	-3%	-$25.5K	﹤0.01%	1731
2019 Q3	$844K	Sell	31,468 -1,707	-5%	-$47.9K	﹤0.01%	1573
2019 Q2	$900K	Buy	33,175 +23,995	+261%	+$752K	﹤0.01%	1564
2019 Q1	$319K	Buy	+9,180	New	+$265K	﹤0.01%	2197
2018 Q4	–	Sell	-8,041	Closed	-$214K	–	2925
2018 Q3	$214K	Sell	8,041 -820	-9%	-$26.8K	﹤0.01%	2491
2018 Q2	$335K	Sell	8,861 -230	-3%	-$8.8K	﹤0.01%	2164
2018 Q1	$297K	Buy	9,091 +739	+9%	+$32.4K	﹤0.01%	2036
2017 Q4	$407K	Buy	8,352 +900	+12%	+$45.5K	﹤0.01%	1829
2017 Q3	$403K	Buy	7,452 +3,044	+69%	+$179K	﹤0.01%	1839
2017 Q2	$248K	Buy	+4,408	New	+$177K	﹤0.01%	2079

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

Raymond James Financial Services Advisors's PTLA Position: Q1 2020 in Review

Raymond James Financial Services Advisors sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 30,543 shares — an estimated $729K sold.

Raymond James Financial Services Advisors first reported a position in PTLA in Q2 2017 and held it in 10 quarters. The position peaked at $900K in Q2 2019. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

Raymond James Financial Services Advisors reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
Raymond James Financial Services Advisors sold 30,543 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $729K.
Raymond James Financial Services Advisors first reported a position in Portola Pharmaceuticals, Inc. in Q2 2017 and held it in 10 quarters.
Raymond James Financial Services Advisors's Portola Pharmaceuticals, Inc. position peaked at $900K in Q2 2019.
187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on Raymond James Financial Services Advisors's 13F filing for Q1 2020, filed 21 Apr 2020.